Anti-androgens in the treatment of prostate cancer and risk of secondary cancers: Overview of non clinical models and regulatory perspectives

被引：0
|
作者：
Belhouari, H. [1 ]
Vidil, F. [1 ]
Louin, G. [1 ]
Burbank, M. [1 ]
Richard, A. [1 ]
Salomon, V. [1 ]
机构：
[1] ANSM, DMS, St Denis, France
来源：
TOXICOLOGY LETTERS | 2021年 / 350卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P13-20
引用
收藏
页码：S156 / S157
页数：2
相关论文
共 22 条
  • [1] Anti-androgens in the treatment of prostate cancer
    Newling, DWW
    BRITISH JOURNAL OF UROLOGY, 1996, 77 (06): : 776 - 784
  • [2] ANTI-ANDROGENS IN TREATMENT OF PROSTATE-CANCER
    LABRIE, F
    CRAWFORD, D
    LANCET, 1995, 346 (8981): : 1030 - 1031
  • [3] ANTI-ANDROGENS IN TREATMENT OF PROSTATE-CANCER - REPLY
    DALESIO, O
    PETO, R
    SCHRODER, F
    LANCET, 1995, 346 (8981): : 1031 - 1031
  • [4] Are non-steroidal anti-androgens appropriate as monotherapy in advanced prostate cancer?
    Boccon-Gibod, L
    EUROPEAN UROLOGY, 1998, 33 (02) : 159 - 164
  • [5] 1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer Treatment
    Ferroni, Claudia
    Pepe, Antonella
    Kim, Yeong Sang
    Lee, Sunmin
    Guerrini, Andrea
    Parenti, Marco Daniele
    Tesei, Anna
    Zamagni, Alice
    Cortesi, Michela
    Zaffaroni, Nadia
    De Cesare, Michelandrea
    Beretta, Giovanni Luca
    Trepel, Jane B.
    Malhotra, Sanjay V.
    Varchi, Greta
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (07) : 3082 - 3093
  • [6] NEW SYSTEMIC TREATMENT FOR PROSTATE CANCER - NOVEL ANTI-ANDROGENS, BONE AGENTS AND CHEMOTHERAPY
    Gurney, H.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 28 - 28
  • [7] The development of anti-androgens with a novel mechanism of action for treatment of castration-resistant prostate cancer
    Munuganti, Ravi Shashi Nayana
    Hassona, Mohamed D. H.
    Leblanc, Eric
    Ban, Fuqiang
    Guns, Emma T.
    Rennie, Paul S.
    Cherkasov, Artem
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis
    Bakouny, Ziad
    Yekeduz, Emre
    Braun, David A.
    Berchuck, Jacob E.
    Hirsch, Laure
    Utkan, Gungor
    Lee, Yi
    Trinh, Quoc-Dien
    Choueiri, Toni K.
    Urun, Yuksel
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 166
  • [9] Second generation anti-androgens and androgen deprivation therapy with radiation therapy in the definitive management of high-risk prostate cancer
    Edina C. Wang
    W. Robert Lee
    Andrew J. Armstrong
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 30 - 40
  • [10] Adjuvant hormone therapy in intermediate-high risk prostate cancer: LH-RH agonist versus anti-androgens
    Capuccini, J.
    Macchia, G.
    Giaccherini, L.
    Zompatori, M.
    Nuzzo, G.
    Mattiucci, G. C.
    Ntreta, M.
    Deodato, F.
    Valentini, V.
    Morganti, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S365 - S365
123